OBJECTIVE: To examine the differential in cancer survival between Indigenous and non-Indigenous people in Queensland in relation to time after diagnosis, remoteness and area-socioeconomic disadvantage. DESIGN, SETTING AND PARTICIPANTS: Descriptive study of population-based data on all 150,059 Queensland residents of known Indigenous status aged 15 years and over who were diagnosed with a primary invasive cancer during 1997-2006. MAIN OUTCOME MEASURES: Hazard ratios for the categories of area-socioeconomic disadvantage, remoteness and Indigenous status, as well as conditional 5-year survival estimates. RESULTS: Five-year survival was lower for Indigenous people diagnosed with cancer (50.3%; 95% CI, 47.8%-52.8%) compared with non-Indigenous people (61.9%; 95% CI, 61.7%-62.2%). There was no evidence that this differential varied by remoteness (P = 0.780) or area-socioeconomic disadvantage (P = 0.845). However, it did vary by time after diagnosis. In a time-varying survival model stratified by age, sex and cancer type, the 50% excess mortality in the first year (adjusted HR, 1.50; 95% CI, 1.38-1.63) reduced to near unity at 2 years after diagnosis (HR, 1.03; 95% CI, 0.78-1.35). CONCLUSIONS: After a wide disparity in cancer survival in the first 2 years after diagnosis, Indigenous patients with cancer who survive these 2 years have a similar outlook to non-Indigenous patients. Access to services and socioeconomic factors are unlikely to be the main causes of the early lower Indigenous survival, as patterns were similar across remoteness and area-socioeconomic disadvantage. There is an urgent need to identify the factors leading to poor outcomes early after diagnosis among Indigenous people with cancer.
OBJECTIVE: To examine the differential in cancer survival between Indigenous and non-Indigenous people in Queensland in relation to time after diagnosis, remoteness and area-socioeconomic disadvantage. DESIGN, SETTING AND PARTICIPANTS: Descriptive study of population-based data on all 150,059 Queensland residents of known Indigenous status aged 15 years and over who were diagnosed with a primary invasive cancer during 1997-2006. MAIN OUTCOME MEASURES: Hazard ratios for the categories of area-socioeconomic disadvantage, remoteness and Indigenous status, as well as conditional 5-year survival estimates. RESULTS: Five-year survival was lower for Indigenous people diagnosed with cancer (50.3%; 95% CI, 47.8%-52.8%) compared with non-Indigenous people (61.9%; 95% CI, 61.7%-62.2%). There was no evidence that this differential varied by remoteness (P = 0.780) or area-socioeconomic disadvantage (P = 0.845). However, it did vary by time after diagnosis. In a time-varying survival model stratified by age, sex and cancer type, the 50% excess mortality in the first year (adjusted HR, 1.50; 95% CI, 1.38-1.63) reduced to near unity at 2 years after diagnosis (HR, 1.03; 95% CI, 0.78-1.35). CONCLUSIONS: After a wide disparity in cancer survival in the first 2 years after diagnosis, Indigenous patients with cancer who survive these 2 years have a similar outlook to non-Indigenous patients. Access to services and socioeconomic factors are unlikely to be the main causes of the early lower Indigenous survival, as patterns were similar across remoteness and area-socioeconomic disadvantage. There is an urgent need to identify the factors leading to poor outcomes early after diagnosis among Indigenous people with cancer.
Authors: Peter D Baade; Patrick Royston; Philipa H Youl; Martin A Weinstock; Alan Geller; Joanne F Aitken Journal: BMC Cancer Date: 2015-01-31 Impact factor: 4.430
Authors: Suzanne P Moore; David Forman; Marion Piñeros; Sdenka M Fernández; Marceli de Oliveira Santos; Freddie Bray Journal: Cancer Med Date: 2013-12-03 Impact factor: 4.452
Authors: Lisa J Whop; Abbey Diaz; Peter Baade; Gail Garvey; Joan Cunningham; Julia M L Brotherton; Karen Canfell; Patricia C Valery; Dianne L O'Connell; Catherine Taylor; Suzanne P Moore; John R Condon Journal: BMJ Open Date: 2016-02-12 Impact factor: 2.692
Authors: Paul Henry Yerrell; David Roder; Margaret Cargo; Rachel Reilly; David Banham; Jasmine May Micklem; Kim Morey; Harold Bundamurra Stewart; Janet Stajic; Michael Norris; Alex Brown Journal: BMJ Open Date: 2016-12-23 Impact factor: 2.692
Authors: Francisco I Torres-Rojas; Miguel A Mendoza-Catalán; Luz Del C Alarcón-Romero; Isela Parra-Rojas; Sergio Paredes-Solís; Marco A Leyva-Vázquez; Jair E Cortes-Arciniega; Carlos J Bracamontes-Benítez; Berenice Illades-Aguiar Journal: PeerJ Date: 2021-06-17 Impact factor: 2.984
Authors: John R Condon; Xiaohua Zhang; Peter Baade; Kalinda Griffiths; Joan Cunningham; David M Roder; Michael Coory; Paul L Jelfs; Tim Threlfall Journal: Popul Health Metr Date: 2014-01-31
Authors: Suzanne P Moore; Adèle C Green; Freddie Bray; Gail Garvey; Michael Coory; Jennifer Martin; Patricia C Valery Journal: BMC Cancer Date: 2014-07-18 Impact factor: 4.430